Opioid partial agonist buprenorphine dampens responses to psychosocial stress in humans
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Preclinical and clinical evidence indicates that opioid drugs have stress-dampening effects. In animal models, opioid analgesics attenuate responses to isolation distress, and in humans, opioids reduce stress related to anticipation of physical pain. The stress-reducing effects of opioid drugs may contribute to their abuse potential. Despite this evidence in laboratory animals, the effects of opioids on responses to psychosocial stress have not been determined in humans. Here we examined the effects of buprenorphine, a μ-opioid partial agonist used to treat opioid dependence and pain, on subjective and physiological responses to a stressful public speaking task in healthy adults. We hypothesized that buprenorphine would reduce subjective and physiological stress responses. Healthy adult volunteers (N = 48) were randomly assigned to receive placebo, 0.2mg sublingual buprenorphine, or 0.4mg sublingual buprenorphine in a two-session study with a stressful speaking task (Trier Social Stress Test; TSST) and a non-stressful control task. During the sessions, the participants reported on their mood states, provided subjective appraisals of the task, and measures of salivary cortisol, heart rate, and blood pressure at regular intervals. Stress produced its expected effects, increasing heart rate, blood pressure, salivary cortisol, and subjective ratings of anxiety and negative mood. In line with our hypothesis, both doses of buprenorphine significantly dampened salivary cortisol responses to stress. On self-report ratings, buprenorphine reduced how threatening participants found the tasks. These results suggest that enhanced opioid signaling dampens responses to social stress in humans, as it does in laboratory animals. This stress-dampening effect of buprenorphine may contribute to the non-medical use of opioid drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kirschbaum, C., Pirke, K.-M., & Hellhammer, D. H. (2008) · Neuropsychobiology · doi:10.1159/000119004 · Cited by 6,093
Kirschbaum, C., Kudielka, B. M., Gaab, J., Schommer, N. C., & Hellhammer, D. H. (1999) · Psychosomatic Medicine · doi:10.1097/00006842-199903000-00006 · Cited by 1,890 · cited 1×
“Women were tested during the follicular stage of their menstrual cycle (days 2—14) to control for effects of hormonal fluctuations on stress responses (Kirschbaum et al., 1999).”
How does stress increase risk of drug abuse and relapse?
Sinha, R. (2001) · Psychopharmacology · doi:10.1007/s002130100917 · Cited by 1,505
β-Endorphin and Adrenocorticotropin Are Selected Concomitantly by the Pituitary Gland
Guillemin, R., Vargo, T., Rossier, J., Minick, S., Ling, N., Rivier, C., Vale, W., & Bloom, F. (1977) · Science · doi:10.1126/science.197601 · Cited by 1,419 · cited 1×
“The endogenous opioid endorphin shares a common precursor with ACTH, and when cortisol release is stimulated, endorphins are also produced (Guillemin et al., 1977; Bodnar, 2013).”
BackgroundThe Dysphoric Component of Stress Is Encoded by Activation of the Dynorphin κ-Opioid System
Land, B. B., Bruchas, M. R., Lemos, J. C., Xu, M., Melief, E. J., & Chavkin, C. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4458-07.2008 · Cited by 601
Gaab, J., Rohleder, N., Nater, U. M., & Ehlert, U. (2005) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2005.02.001 · Cited by 525 · cited 1×
“mmediately before performing the verbal tasks, particiants completed the Primary Appraisal Secondary Appraisal ating scale (Gaab et al., 2005) to rate their perception f the tasks before completing them.”
MethodRole of endogenous opioid system in the regulation of the stress response
Drolet, G., Dumont, É. C., Gosselin, I., Kinkead, R., Laforest, S., & Trottier, J.-F. (2001) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(01)00161-0 · Cited by 421 · cited 2×
“In laboratory animals, exposure to tress leads to the up-regulation of - and -opioid receptor xpression in some of these areas, such as the hypothalmus (Drolet et al., 2001; Yamamoto et al., 2003), and ice lacking the -opioid receptor gene (OPRM1) exhibit educed cortisol responses to stress (Ide et al.”
Herman, B. H., & Panksepp, J. (1978) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(78)90167-3 · Cited by 330
Social Defeat Stress-Induced Behavioral Responses are Mediated by the Endogenous Kappa Opioid System
McLaughlin, J. P., Li, S., Valdez, J., Chavkin, T. A., & Chavkin, C. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300872 · Cited by 253
Opiate modulation of separation-induced distress in non-human primates
Kalin, N. H., Shelton, S. E., & Barksdale, C. M. (1988) · Brain Research · doi:10.1016/0006-8993(88)90997-3 · Cited by 182
Buprenorphine has potent kappa opioid receptor antagonist activity
LEANDER, J. (1987) · Neuropharmacology · doi:10.1016/0028-3908(87)90112-2 · Cited by 140
Depressive symptoms during buprenorphine treatment of opioid abusers
Kosten, T. R., Morgan, C., & Kosten, T. A. (1990) · Journal of Substance Abuse Treatment · doi:10.1016/0740-5472(90)90035-o · Cited by 110 · cited 1×
“…drugs reduce reactivity to stressful stimuli, and it has been suggested that the anxiolytic or stress-dampening effects of buprenorphine may contribute to its efficacy in treating opioid addiction, independently of its role as a replacement therapy (Kosten et al., 1990; Maremmani et al., 2006).”
BackgroundStress modulates illness-course of substance use disorders: a translational review
Lijffijt, M., Hu, K., & Swann, A. C. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00083 · Cited by 103
The Role of Amygdalar Mu-Opioid Receptors in Anxiety-Related Responses in Two Rat Models
Wilson, M. A., & Junor, L. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301675 · Cited by 76 · cited 2×
“Further, -opioid agonists reduce isolation distress vocalizations (Herman and Panksepp, 1978; Stein et al., 2007), responses to predator odors (Wilson and Junor, 2008), anxiety-like behavior in the elevated plus maze (Kahveci et al., 2006), and fear acquisition (Good and Westbrook, 1995).”
Background
Cited by
Simultaneous measurement of salivary cortisol and alpha-amylase: Application and recommendations
Strahler, J., Skoluda, N., Kappert, M. B., & Nater, U. M. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.08.015 · Cited by 259
Reinforcement learning in depression: a review of computational research
Chen, C., Takahashi, T., Nakagawa, S., Inoue, T., & Kusumi, I. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.05.005 · Cited by 233
Opioid system and human emotions
Nummenmaa, L., & Tuominen, L. (2018) · British Journal of Pharmacology · doi:10.1111/bph.13812 · Cited by 178
Carlezon, W. A., & Krystal, A. D. (2016) · Depression and Anxiety · doi:10.1002/da.22500 · Cited by 158
“[93] Lastly, one double-blind, placebo-controlled study including 48 healthy controls found evidence that buprenorphine diminishes the response to social stress that was elicited with the Trier Social Stress Test.”
The role of the opioid system in decision making and cognitive control: a review
van Steenbergen, H., Eikemo, M., & Leknes, S. (2019) · Cognitive, Affective, & Behavioral Neuroscience · doi:10.3758/s13415-019-00710-6 · Cited by 118
Metadata
- Authors
- Bershad, A. K., Jaffe, J. H., Childs, E., & de Wit, H.
- Venue
- Psychoneuroendocrinology
- Publisher
- Elsevier BV
- Published
- 2015-02
- Volume
- 52
- Pages
- 281-288
- ISSN
- 0306-4530 (ISSN-L)
- OpenAlex
- W1995367677
- Cited by
- 94
- References
- 14
- FWCI
- 3.29
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.